Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIT to Dust Mites in Children With Asthma
NCT00496561Phase 4Unknown
- Sponsor
- Medical University of Lodz
- Start
- Aug 2006
- Primary completion
- Nov 2013
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of House dust mite allergen extract in asthma (2 arms), sponsored by Medical University of Lodz. Primary endpoints: Clinical symptoms at 24 months, Reliever drugs usage at 24 months and 5 more. Status: unknown.
02
Drugs
House dust mite allergen extract
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00496561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496561.